Aptose Biosciences
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $955 |
Gross Profit | -117 | -108 | ||
EBITDA | -1,056 | -6,961 | -7,337 | -9,651 |
EBIT | -1,153 | -6,965 | -7,439 | -9,760 |
Net Income | -1,585 | -6,953 | -7,252 | -9,640 |
Net Change In Cash | 0 | 0 | 0 | 955 |
Free Cash Flow | -8,065 | -10,376 | -5,778 | -11,709 |
Cash | 6,152 | 7,962 | 8,330 | 7,346 |
Basic Shares | 11,959 | 18,559 | 16,754 | 13,132 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -474 | -507 | -616 | |
EBITDA | -52,268 | -42,482 | -65,297 | |
EBIT | -52,356 | -42,602 | -65,447 | |
Net Income | -25,430 | -51,207 | -41,823 | -65,354 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -2,140 | -78,279 | ||
Free Cash Flow | -35,982 | -44,619 | -32,346 | -43,516 |
Cash | 6,152 | 9,252 | 36,970 | 39,114 |
Basic Shares | 23,299 | 6,755 | 6,151 | 5,939 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$34.90 |
2024-09-30 | -$0.37 |
2024-06-30 | -$0.43 |
2024-03-31 | -$0.73 |
